تدبير الزرق الصباغي وأهمية الكشف المبكر
Abstract
يوضح هذا البحث ضرورة الاهتمام بالزرق الصباغي إذ يصيب عادة الشبان الذكور الحسيرين بين أواخر العشرين وحتى أواخر الثلاثين, ويخلص إلى أهمية الكشف المبكر للمرض كونه لا عرضي في 50 % من الحالات ويستجيب بشكل جيد للمعالجة المحافظة 76.67 %.
تمت الدراسة على 30 مريضاً شخص الزرق الصباغي لديهم اعتماداً على الفحص الاستقصائي والأعراض السريرية.
قسم المرضى عشوائياً من حيث نمط المعالجة إلى مجموعتين خضعت إحداهما للمعالجة الدوائية 66.7 % ( 20 مريضاً ), فيما خضعت الأخرى للمعالجة الليزرية بالآرغون ليزرALT 13.3 % ( 10 مرضى ).
وكانت النتائج:
نسبة إصابة الذكور 76.7 %
نسبة المرضى الحسيرين 53.3 %
نسبة الاستجابة للمعالجة الدوائية 80 % ونسبة عدم الاستجابة 20 %
نسبة الاستجابة للمعالجة بالآرغون ليزرALT 70 % ونسبة عدم الاستجابة 30 %
نسبة الاستجابة لنمطي المعالجة المحافظة 76.67 %
كانت الاختلاطات المشاهدة لنمطي العلاج قليلة وقد تمت السيطرة عليها.
خضعت الحالات الغير مستجيبة لنمطي العلاج 23.33 % للجراحة الراشحة.
This study tries to explain the importance of pigmentary glaucoma as it happened among myopic male adults between 20 up to 40 years old, and indicates the importance of early diagnosis since the disease has no symptoms in 50 % and responds well to non surgical treatments 76.67 %.
The study included 30 patients: 20 patients ( 66.7% ) underwent medical treatment, and 10 patients ( 13.3 % ) underwent Argon Laser Trabeculplasty ( ALT ).
The results were as follows:
- ·76.7 % were men.
- ·53.3 % was myope.
- ·The response to medical therapy was 80 % , and no response was 20 %.
- ·The response to ALT was 70 % , and noresponse was 30 %.
- ·The response to both type of treatment was 76.67 %.
- ·53.3 % was myope.
Complications were rare 23.33 % and failure cases underwent trabeculectomy.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.